+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bleeding Disorder"

From
Bleeding Disorders Treatment Market Report 2025 - Product Thumbnail Image

Bleeding Disorders Treatment Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Bleeding Disorder Testing Market Report 2024 - Product Thumbnail Image

Bleeding Disorder Testing Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
From
From
Hemophilia B - Global Strategic Business Report - Product Thumbnail Image

Hemophilia B - Global Strategic Business Report

  • Report
  • March 2025
  • 188 Pages
  • Global
From
Rare Hemophilia Factors - Global Strategic Business Report - Product Thumbnail Image

Rare Hemophilia Factors - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
Blood Plasma Derivatives Market Report 2025 - Product Thumbnail Image

Blood Plasma Derivatives Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Rare Haematology Disorders Market Report and Forecast 2024-2032 - Product Thumbnail Image

Rare Haematology Disorders Market Report and Forecast 2024-2032

  • Report
  • September 2024
  • 250 Pages
  • Global
From
Loading Indicator

The Bleeding Disorder market is a subset of the Hematology market, which focuses on the diagnosis, treatment, and prevention of blood-related diseases. Bleeding Disorders are a group of conditions that affect the body's ability to control bleeding. These disorders can be caused by a variety of factors, including genetic mutations, acquired conditions, and environmental factors. Common bleeding disorders include hemophilia, von Willebrand disease, and platelet disorders. Treatment for these disorders typically involves the use of clotting factor concentrates, antifibrinolytic agents, and other medications. The Bleeding Disorder market is highly competitive, with a number of companies offering products and services to treat these conditions. Some of the major players in the market include Novo Nordisk, Pfizer, Bayer, CSL Behring, and Shire. Show Less Read more